经导管动脉栓塞治疗原发性肝癌的疗效及对预后的影响  

Efficacy of transcatheter arterial chemoembolization in the treatment of primary liver cancer and its impactonpatientprognosis

作　　者：王钧 WANG Jun(Ziyang Traditional Chinese Medicine Hospital,Ziyang,Sichuan 641300,China)

机构地区：[1]资阳市中医医院,四川资阳641300

出　　处：《中国国境卫生检疫杂志》2023年第S01期12-14,共3页Chinese Journal of Frontier Health and Quarantine

摘　　要：目的研究原发性肝癌患者应用经导管动脉栓塞化疗治疗的效果、对于预后的影响。方法选择我院在2021年3月-2023年2月期间接收的76例患者,随机分为两组,比较患者的治疗效果。结果研究组的治疗效果更好,差异有统计学意义(P<0.05)。结论原发性肝癌的患者,使用经导管动脉栓塞化疗治疗的方式具有显著的效果,可以明显改善的肝功能与肿瘤情况,提升患者的生活质量,降低患者的复发。Objective To study the efficacy and prognostic impact of transcatheter arterial chemoembolization in patients with primary liver cancer.Methods 76 patients who were admitted to our hospital from March 2021 to February 2023 were randomly divided into two groups to compare their treatment effects.Results The treatment effect of the research group was better,with significant differences(P<0.05).Conclusion For patients with primary liver cancer,the use of transcatheter arterial embolization chemotherapy has significant effects,which can significantly improve liverfunction and tumor conditions,improvepatientquality of life.

关 键 词：原发性肝癌 经导管动脉栓塞化疗治疗 治疗效果 预后 肝功能 

分 类 号：R735.7[医药卫生—肿瘤]